FIELD: medicine.
SUBSTANCE: invention relates to the use of an inhibitor of dipeptidyl peptidase-3 (hereinafter – DPP3) activity for the treatment of a disease or condition accompanied or related to necrotic processes in an individual. The inhibitor of DPP3 activity is an anti-DPP3 antibody, a fragment of an anti-DPP3 antibody or scaffold protein, other than Ig, against DPP3, which bind to SEQ ID NO:1 or SEQ ID NO:2. The disease is selected from a group including heart failure, chronic heart failure, acute heart failure (AHF), myocardial infarction (MI), stroke, liver failure, burn injuries, traumatic injuries, microbial infection, AIDS, malaria, SIRS, sepsis, cancer, acute kidney failure (AKI), seizures, neurodegenerative diseases, autoimmune diseases, vascular diseases and hypotension.
EFFECT: invention provides for the treatment of a disease or condition in an individual accompanied or related to necrotic processes, using an inhibitor of DDP3 activity.
5 cl, 12 tbl, 11 dwg, 14 ex
| Title |
Year |
Author |
Number |
| THERAPEUTIC GUIDANCE AND/OR MONITORING THERAPY FOR TREATING SHOCK |
2020 |
|
RU2835616C1 |
| DPP3-BINDING MOLECULE AIMED AT SPECIFIC DPP3 EPITOPES AND BINDING TO THEM AND ITS USE FOR PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS, WHICH ARE RELATED TO OXIDATIVE STRESS |
2018 |
|
RU2787033C2 |
| DPP3 FOR IMPLEMENTATION, MONITORING AND STRATIFICATION OF THERAPY WITH NT-ADM ANTIBODIES IN PATIENTS WITH SHOCK |
2021 |
|
RU2838370C1 |
| METHODS AND MATERIALS FOR ASSESSMENT OF RESPONSE TO THERAPY AGAINST PLASMA-BLASTS AND PLASMA CELLS |
2017 |
- Smithson, Glennda
- Estevam, Jose
- Jones, Nicholas
|
RU2787629C2 |
| NGF ANTIBODIES AND RELATED METHODS |
2019 |
- Steiniger Sebastian C. J.
- Dunkle William
- Rugg Catherine
- Dunham Steven A.
|
RU2838175C2 |
| HUMANISED HUMAN CD19 ANTIBODIES AND METHODS FOR USE THEREOF |
2016 |
- Zhorzh Gi
- Messner Ekkekhard
- Lariver Loran
- Khaas Aleksandr
- Kettenberger Gubert
- Ferrara Koller Klaudia
- Shlotauer Tilman
- Molkhoj Mikhel
|
RU2731156C1 |
| FGF21 MIMETIC ANTIBODIES AND THEIR APPLICATION METHODS |
2018 |
- Cebe, Regis
- Yowe, David Langdon
- Olland, Stephane
|
RU2774368C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER |
2018 |
- Shanto, Stefani
- Gurden, Nikolya
- Paturel, Karin
- Perro, Ivan
- Rossi, Benzhamin
|
RU2781116C1 |
| ANTIBODIES SPECIFIC TO MMP9 |
2015 |
- Chvatchko Missotten Ioland
- Goffen Lorans
- Lezher Olive
- Dann Stiven M.
- Pauer Kristin
- Mondrel Kinsi
|
RU2714043C2 |
| ANTIBODY AGAINST ADRENOMEDULLIN (ADM), OR FRAGMENT OF ANTI-ADM ANTIBODY, OR ANTI-ADM NON-IG FRAME FOR USE IN INTERVENTION AND THERAPY OF HYPEREMIA IN PATIENT |
2017 |
|
RU2762059C2 |
